SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-22-003021
Filing Date
2022-04-29
Accepted
2022-04-29 07:51:38
Documents
12
Period of Report
2022-04-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K isco-8k.htm   iXBRL 8-K 23054
  Complete submission text file 0001683168-22-003021.txt   188395

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE isco-20220425.xsd EX-101.SCH 2998
3 XBRL LABEL FILE isco-20220425_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE isco-20220425_pre.xml EX-101.PRE 22385
6 EXTRACTED XBRL INSTANCE DOCUMENT isco-8k_htm.xml XML 3182
Mailing Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008
Business Address 5950 PRIESTLY DRIVE CARLSBAD CA 92008 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51891 | Film No.: 22870251
SIC: 2834 Pharmaceutical Preparations